While many studies have demonstrated the potential of NfL and GFAP, most of them have focused on predicting progression from MCI to dementia [19, 47, 48], whereas only a few studies have investigated the pathologic substrate of MCI defined according to AD biomarkers [19, 42, 44]. This evidence concerns the gene GFAP and dementia.